Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
28.13
-0.52 (-1.82%)
At close: Sep 5, 2025, 4:00 PM
28.50
+0.37 (1.32%)
After-hours: Sep 5, 2025, 5:29 PM EDT
Apellis Pharmaceuticals (APLS) Product Revenue by Segment
History
| Date | Syfovre | Empaveli |
|---|---|---|
| Jun 30, 2025 | 600.59M | 88.47M |
| Mar 31, 2025 | 604.58M | 92.22M |
| Dec 31, 2024 | 611.85M | 98.13M |
| Sep 30, 2024 | 558.35M | 99.13M |
| Jun 30, 2024 | 481.67M | 98.42M |
| Mar 31, 2024 | 394.39M | 96.21M |
| Dec 31, 2023 | 275.28M | 91.04M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.